Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Study protocol

A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial

Authors: Karen Broekhuizen, Mireille NM van Poppel, Lando LJ Koppes, Johannes Brug, Willem van Mechelen

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

Because of a high cardiovascular disease (CVD) risk in people with Familial Hypercholesterolemia (FH), early prevention of cardiovascular disease is important for health gain and cost reduction. This project focuses on the development and evaluation of an innovative intervention aiming to reduce CVD risk by promoting a healthy lifestyle among people with FH.

Methods

This project is designed as a randomised controlled trial in which individuals with FH will be assigned randomly to a control or intervention group. In the intervention group (n = 200), participants will receive a personalized intervention which is a combination of web-based tailored lifestyle advice and personal counselling by a lifestyle coach. The control group (n = 200) will receive care as usual. Primary outcomes are biological indicators of CVD risk: systolic blood pressure, glucose, BMI, waist circumference and lipids (triglycerides, total, LDL and HDL cholesterol). Secondary outcomes are: healthy lifestyle behaviour (with regard to smoking, physical activity, dietary pattern and compliance to statin therapy) and psychological correlates and determinants of healthy lifestyle behaviour (knowledge, attitude, risk perception, social influence, self-efficacy, cues to action, intention and autonomy). Measurement will take place at baseline, and at 3 and 12 months after randomisation. Additionally, a throughout process-evaluation will be conducted to assess and monitor intervention implementation during the trial.

Discussion

Results of the PRO-FIT project will provide information about the effects and implementation of a healthy lifestyle intervention for individuals with FH. Our experiences with this intervention will be indicative about the suitability, feasibility and benefits of this approach for future interventions in other high-risk groups, such as Familial Combined Hypercholesterolemia (FCH) and diabetes.

Trial registration number

NTR1899
Appendix
Available only for authorised users
Literature
1.
Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson DL, Loscalzo J: Harrison's principles of internal medicine. 2008, New York: McGraw-Hill Medical Publishing Division
2.
Lansberg PJ, Tuzgol S, van de Ree MA, Defesche JC, Kastelein JJ: Higher prevalence of familial hypercholesterolemia than expected in adult patients of four family practices in Netherlands. Ned Tijdschr Geneeskd. 2000, 144: 1437-1440.PubMed
3.
Stichting Opsporing Erfelijke Hypercholesterolemie. Jaarverslag 2007. 2008
4.
Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ. 1991, 303: 893-896. 10.1136/bmj.303.6807.893.
5.
Treurniet HF, Hoeymans N, Gijsen R, Poos MJ, van Oers JA, Thien WM: Health status and the challenges for prevention in The Netherlands. Public Health. 2005, 119: 159-166. 10.1016/j.puhe.2004.05.018.CrossRefPubMed
6.
Yuan G, Wang J, Hegele RA: Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ. 2006, 174: 1124-1129.CrossRefPubMedPubMedCentral
7.
Marteau T, Senior V, Humphries SE, Bobrow M, Cranston T, Crook MA, Day L, Fernandez M, Horne R, Iversen A, et al: Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am J Med Genet A. 2004, 128A: 285-293. 10.1002/ajmg.a.30102.CrossRefPubMed
8.
van Maarle MC, Stouthard ME, Bonsel GJ: Risk perception of participants in a family-based genetic screening program on familial hypercholesterolemia. Am J Med Genet A. 2003, 116A: 136-143. 10.1002/ajmg.a.10061.CrossRefPubMed
9.
Souverein OW, Defesche JC, Zwinderman AH, Kastelein JJ, Tanck MW: Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia. Eur Heart J. 2007, 28: 299-304. 10.1093/eurheartj/ehl366.CrossRefPubMed
10.
Hegele RA: Environmental modulation of atherosclerosis end points in familial hypercholesterolemia. Atheroscler Suppl. 2002, 2: 5-7. 10.1016/S1567-5688(01)00013-7.CrossRefPubMed
11.
Austin MA, Hutter CM, Zimmern RL, Humphries SE: Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol. 2004, 160: 421-429. 10.1093/aje/kwh237.CrossRefPubMed
12.
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, et al: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005, 366: 1267-1278. 10.1016/S0140-6736(05)67394-1.CrossRefPubMed
13.
Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent C: Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008, 371: 117-125. 10.1016/S0140-6736(08)60761-8.CrossRefPubMed
14.
Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, et al: The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol. 2008, 102: 1K-34K. 10.1016/j.amjcard.2008.10.002.CrossRefPubMed
15.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.
16.
Umans-Eckenhausen MA, Defesche JC, van Dam MJ, Kastelein JJ: Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia. Arch Intern Med. 2003, 163: 65-68. 10.1001/archinte.163.1.65.CrossRefPubMed
17.
Civeira F: Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004, 173: 55-68. 10.1016/j.atherosclerosis.2003.11.010.CrossRefPubMed
18.
Kromhout D, Menotti A, Kesteloot H, Sans S: Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies. Circulation. 2002, 105: 893-898. 10.1161/hc0702.103728.CrossRefPubMed
19.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed
20.
de Vries H, Mesters I, Riet JV, Willems K, Reubsaet A: Motives of Belgian adolescents for using sunscreen: the role of action plans. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1360-1366. 10.1158/1055-9965.EPI-05-0877.CrossRefPubMed
21.
Ajzen I: From intentions to actions: A theory of planned behavior. Action control: From cognition to behavior. Edited by: Kuhl J, Beckmann J. 1985, Berlin, Heidelberg, New York: Springer-Verlag
22.
Hawley ST, Zikmund-Fisher B, Ubel P, Jancovic A, Lucas T, Fagerlin A: The impact of the format of graphical presentation on health-related knowledge and treatment choices. Patient Educ Couns. 2008, 73: 448-455. 10.1016/j.pec.2008.07.023.CrossRefPubMed
23.
Kroeze W, Werkman A, Brug J: A systematic review of randomized trials on the effectiveness of computer-tailored education on physical activity and dietary behaviors. Ann Behav Med. 2006, 31: 205-223. 10.1207/s15324796abm3103_2.CrossRefPubMed
24.
Brug J, Oenema A, Campbell M: Past, present, and future of computer-tailored nutrition education. Am J Clin Nutr. 2003, 77: 1028S-1034S.PubMed
25.
Oenema A, Brug J, Dijkstra A, de Weerdt I, de Vries H: Efficacy and use of an internet-delivered computer-tailored lifestyle intervention, targeting saturated fat intake, physical activity and smoking cessation: a randomized controlled trial. Ann Behav Med. 2008, 35: 125-135. 10.1007/s12160-008-9023-1.CrossRefPubMed
26.
Miller WR, Rollnick S: Motivational interviewing: Preparing people for change. 2002, New York: Guilford Press
27.
Rubak S, Sandbaek A, Lauritzen T, Christensen B: Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005, 55: 305-312.PubMedPubMedCentral
28.
Dunn C, Deroo L, Rivara FP: The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2001, 96: 1725-1742. 10.1046/j.1360-0443.2001.961217253.x.CrossRefPubMed
29.
Burke BL, Arkowitz H, Menchola M: The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003, 71: 843-861. 10.1037/0022-006X.71.5.843.CrossRefPubMed
30.
Resnicow K, Jackson A, Wang T, De AK, McCarty F, Dudley WN, Baranowski T: A motivational interviewing intervention to increase fruit and vegetable intake through Black churches: results of the Eat for Life trial. Am J Public Health. 2001, 91: 1686-1693. 10.2105/AJPH.91.10.1686.CrossRefPubMedPubMedCentral
31.
Resnicow K, Jackson A, Braithwaite R, DiIorio C, Blisset D, Rahotep S, Periasamy S: Healthy Body/Healthy Spirit: a church-based nutrition and physical activity intervention. Health Educ Res. 2002, 17: 562-573. 10.1093/her/17.5.562.CrossRefPubMed
32.
Miller WR, Moyers TB, Ernst D, Amrhein PC: Manual for the Motivational Interviewing Skill Code (MISC) Version 2.0. 2003
33.
Moyers TB, Martin T, Manuel JK, Hendrickson SM, Miller WR: Assessing competence in the use of motivational interviewing. J Subst Abuse Treat. 2005, 28: 19-26. 10.1016/j.jsat.2004.11.001.CrossRefPubMed
34.
Moyers TB, Martin T, Manual JK, Miller WR, Ernst D: Revised Global Scales: Motivational Interviewing Treatment Integrity 3.0 (MITI 3.0). 2007, University of New Mexico, Center on Alcoholism, Substance Abuse and Addictions (CASAA), 28:
35.
Truswell AS: Review of dietary intervention studies: effect on coronary events and on total mortality. Internal Medicine Journal. 1994, 24: 98-106. 10.1111/j.1445-5994.1994.tb04444.x.
36.
Issa JS, Strunz C, Giannini SD, Forti N, Diament J: Precision and accuracy of blood lipid analyses by a portable device (Cholestech-LDX). Arq Bras Cardiol. 1996, 66: 339-342.PubMed
37.
Panz VR, Raal FJ, Paiker J, Immelman R, Miles H: Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids. Cardiovasc J S Afr. 2005, 16: 112-117.PubMed
38.
Carey M, Markham C, Gaffney P, Boran C, Maher V: Validation of a point of care lipid analyser using a hospital based reference laboratory. Ir J Med Sci. 2006, 175: 30-35. 10.1007/BF03167964.CrossRefPubMed
39.
Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D: Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol. 2003, 56: 1163-1169. 10.1016/S0895-4356(03)00220-8.CrossRefPubMed
40.
van Assema P, Brug J, Kok G, Brants H: The reliability and validity of a Dutch questionnaire on fat consumption as a means to rank subjects according to individual fat intake. Eur J Cancer Prev. 1992, 1: 375-380. 10.1097/00008469-199208000-00006.CrossRefPubMed
41.
van Assema P, Brug J, Ronda G, Steenhuis I: The relative validity of a short Dutch questionnaire as a means to categorize adults and adolescents to total and saturated fat intake. J Hum Nutr Diet. 2001, 14: 377-390. 10.1046/j.1365-277X.2001.00310.x.CrossRefPubMed
42.
van Assema P, Brug J, Ronda G, Steenhuis I, Oenema A: A short dutch questionnaire to measure fruit and vegetable intake: relative validity among adults and adolescents. Nutr Health. 2002, 16: 85-106.CrossRefPubMed
43.
Mikkelsen TB, Olsen SF, Rasmussen SE, Osler M: Relative validity of fruit and vegetable intake estimated by the food frequency questionnaire used in the Danish National Birth Cohort. Scand J Public Health. 2007, 35: 172-179. 10.1080/14034940600975625.CrossRefPubMed
44.
Mudde AN, Willemsen MC, Kremers S, de Vries H: Meetinstrumenten voor onderzoek naar roken en stoppen met roken. STIVORO. 2000
45.
Horne R, Weinman J: Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999, 47: 555-567. 10.1016/S0022-3999(99)00057-4.CrossRefPubMed
46.
Leventhal H, Benyamini Y, Brownlee S: Illness representations: theoretical foundations. Perceptions of health and illness, current research and applications. Edited by: Petrie KJ, Weinman J. 1997, Amsterdam: Harwoord Academic, 19-45.
47.
Hagger MS, Orbell S: A meta-analytic review of the common-sense model of illness representations. Psychology and Health. 2003, 18: 141-184. 10.1080/088704403100081321.CrossRef
48.
Broadbent E, Petrie KJ, Main J, Weinman J: The brief illness perception questionnaire. J Psychosom Res. 2006, 60: 631-637. 10.1016/j.jpsychores.2005.10.020.CrossRefPubMed
49.
Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D: The Revised Illness Perception Questionnaire(IPQ-R). Psychology and Health. 2002, 17: 1-16. 10.1080/08870440290001494.CrossRef
50.
Claassen L, Henneman L, Kindt I, Marteau T, Timmermans DR: Perceived risk and representations of cardiovascular disease, and preventive behavior in people diagnosed with Familial Hypercholesterolemia by DNA-testing: a cross-sectional questionnaire study. Journal of Health Psychology. 2010, 1: 33-43. 10.1177/1359105309345170.CrossRef
51.
Glasgow RE, Vogt TM, Boles SM: Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999, 89: 1322-1327. 10.2105/AJPH.89.9.1322.CrossRefPubMedPubMedCentral
52.
Saunders RP, Evans MH, Joshi P: Developing a process-evaluation plan for assessing health promotion program implementation: a how-to guide. Health Promot Pract. 2005, 6: 134-147. 10.1177/1524839904273387.CrossRefPubMed
53.
Brooks R: EuroQol: the current state of play. Health Policy. 1996, 37: 53-72. 10.1016/0168-8510(96)00822-6.CrossRefPubMed
Metadata
Title
A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial
Authors
Karen Broekhuizen
Mireille NM van Poppel
Lando LJ Koppes
Johannes Brug
Willem van Mechelen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-69

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue

Research article

Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies

Research article

To bite or not to bite! A questionnaire-based survey assessing why some people are bitten more than others by midges

Research article

Population uptake of antiretroviral treatment through primary care in rural South Africa

Research article

Knowledge of Chlamydia trachomatis among men and women approached to participate in community-based screening, Scotland, UK

Research article

Is web interviewing a good alternative to telephone interviewing? Findings from the International Tobacco Control (ITC) Netherlands Survey

Research article

Urbanization, ethnicity and cardiovascular risk in a population in transition in Nakuru, Kenya: a population-based survey